Valuation: Balchem Corporation

Market Cap 520.99Cr 455.71Cr 420.33Cr 388.22Cr 736.63Cr 50TCr 749.02Cr 5.02TCr 1.97TCr 24TCr 1.96TCr 1.91TCr 84TCr P/E 2026 *
31.2x
P/E 2027 * 30.2x
Enterprise Value 519.8Cr 454.67Cr 419.37Cr 387.33Cr 734.95Cr 50TCr 747.32Cr 5.01TCr 1.97TCr 24TCr 1.95TCr 1.91TCr 84TCr EV / Sales 2026 *
4.69x
EV / Sales 2027 * 4.33x
Free-Float
99.53%
Yield 2026 *
0.7%
Yield 2027 * 0.78%
1 day-0.84%
1 week-3.94%
Current month-4.02%
1 month+0.31%
3 months-7.31%
6 months+1.17%
Current year+5.73%
1 week 161.91
Extreme 161.91
168.8
1 month 161.91
Extreme 161.91
174.09
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 61.03
Extreme 61.03
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
01/04Other

Controller/Auditor

8,646 0.0270%
11/02Free

Director

870 0.0027%
11/02Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-3.94%+0.14%+23.66% 525.42Cr
+0.47%-3.19%+2.82%+49.33% 7.68TCr
+0.41%-2.11%-11.02%+17.33% 3.91TCr
+0.99%-6.81%-22.94%-33.87% 3.2TCr
+0.73%-0.97%+19.73%+30.07% 2.6TCr
-1.21%+0.67%+87.09%-7.79% 2.12TCr
+4.24%+2.22%+14.71%+5.78% 1.98TCr
-0.08%-3.74%-41.03%-36.16% 1.82TCr
-1.85%-7.02%+69.72%-47.45% 1.51TCr
+0.07%-3.02%-2.64%-5.18% 1.39TCr
Average +0.29%-2.74%+11.66%-0.43% 2.68TCr
Weighted average by Cap. +0.48%-2.77%+7.37%+10.43%

Financials

2026 *2027 *
Net sales 110.82Cr 97Cr 89Cr 83Cr 156.69Cr 11TCr 159.33Cr 1.07TCr 419.53Cr 5.21TCr 416.11Cr 407.05Cr 18TCr 116.69Cr 102.07Cr 94Cr 87Cr 164.99Cr 11TCr 167.76Cr 1.12TCr 441.73Cr 5.48TCr 438.13Cr 428.59Cr 19TCr
Net income 17Cr 15Cr 14Cr 13Cr 24Cr 1.6TCr 24Cr 162.15Cr 64Cr 790.29Cr 63Cr 62Cr 2.72TCr 17Cr 15Cr 14Cr 13Cr 25Cr 1.66TCr 25Cr 167.52Cr 66Cr 816.5Cr 65Cr 64Cr 2.81TCr
Net Debt -1.19Cr -1.04Cr -95.7L -88.39L -1.68Cr -113.13Cr -1.71Cr -11Cr -4.49Cr -56Cr -4.45Cr -4.36Cr -191.59Cr -15Cr -13Cr -12Cr -11Cr -22Cr -1.46TCr -22Cr -147.76Cr -58Cr -720.18Cr -58Cr -56Cr -2.48TCr
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,368
Date Price Change Volume
10/26/10 $162.15 -0.84% 2,49,120
09/26/09 $163.53 -1.49% 2,56,170
08/26/08 $166.01 -1.25% 2,85,515
07/26/07 $168.11 +0.66% 2,78,924
06/26/06 $167.01 -1.06% 3,41,373
Trader
Investor
Global
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
162.15USD
Average target price
200.75USD
Spread / Average Target
+23.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock